Drug recall · October 26, 2016
Trokendi XR recall
Why: Superpotent Drug: Failure of assay specifications in the capsule.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850, NDC 17772-102-15
- Lots / codes
Lot # 426636, Exp 4/22/18
- Quantity
- 17,128 (30-count blister packs)
- Company
- Supernus Pharmaceuticals, Inc., Rockville, MD
- Distribution
- Nationwide
- Initiated
- July 12, 2016 · Voluntary: Firm initiated
- Classified
- October 20, 2016
- Reported
- October 26, 2016
- Ended
- February 26, 2019
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Trokendi
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.